Two More Vascular Surgeons Join UF Department of Surgery

Javairiah Fatima, MD

The UF department of surgery’s division of vascular surgery has welcomed two new surgeons.

Javairiah Fatima, M.B., B.S., and Kristina Giles, M.D., are both assistant professors of

Fatima earned her bachelor’s degree in medicine and bachelor’s degree in surgery, together the equivalent of an American medical degree, at the Agha Khan University in Pakistan. She completed a research fellowship in gastrointestinal surgery and her residency training at the Mayo Clinic in Minnesota, followed by a vascular surgery fellowship at the Cleveland Clinic, where she also completed an administrative fellowship.

Currently, she serves also as a reviewer for the journal Vascular and the Journal of Vascular Surgery. Her clinical interests include aortic aneurysm and dissection, mesenteric and renovascular disease, cerebrovascular disease, peripheral vascular disease, quality improvement initiatives and minimally invasive treatment of aortic dissection and of thoracoabdominal aortic aneurysms. Fatima’s research interests center around outcomesbased
translational research in vascular pathology and trials for new vascular devices. She also has an interest in teaching medical students, residents and fellows.

Kristina Giles, MD

Giles’ medical degree is from Mount Sinai School of Medicine. She completed her general surgery residency at Beth Israel Deaconess Medical Center, while also serving as an administrative resident. During residency she completed a research fellowship with the Harvard-Longwood Research Training in Vascular Surgery Program. She then went on to a vascular surgery fellowship at Dartmouth Hitchcock Medical Center.

Her research concentrates on comparative effectiveness and outcomes in vascular surgery, quality improvement and database utilization, and population studies focused on aortic aneurysm repair. Her clinical interests are aortic surgery, cerebrovascular interventions including carotid stenting, lower-extremity bypass procedures and endovascular interventions, and stem cell and gene therapy treatment strategies for patients with nonrevascularizable peripheral vascular disease.